Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
Back to Search Results

Connection

Search Results to Stacie Jones

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Jones, Stacie

Item TypeName
Academic Article Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy.
Academic Article Peanut oral immunotherapy is not ready for clinical use.
Academic Article Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens.
Academic Article Tree nut- and sesame-specific IgE do not decrease from baseline with peanut oral immunotherapy (OIT).
Academic Article Adverse reactions during peanut oral immunotherapy home dosing.
Academic Article A phase II, randomized, double-blind, parallel-group, placebo-controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy.
Academic Article Clinical efficacy and immune regulation with peanut oral immunotherapy.
Academic Article Maternal consumption of peanut during pregnancy is associated with peanut sensitization in atopic infants.
Academic Article Safety of a peanut oral immunotherapy protocol in children with peanut allergy.
Academic Article Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparison.
Academic Article A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response.
Academic Article Allergic reactions to foods in preschool-aged children in a prospective observational food allergy study.
Academic Article Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial.
Concept Peanut Hypersensitivity
Academic Article Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.
Academic Article Clinical and immunologic features of infants in an observational study (CoFAR) who were selected for an increased risk to develop peanut allergy (PNA)
Academic Article A phase II, randomized, double-blind, parallel-group, placebo-controlled, oral food challenge trial of Xolair, (omalizumab) in peanut allergy (TOPS)
Academic Article Camparison of sublingual immunotherapy (SLIT) versus oral immunotherapy (OIT) in the treatment of peanut allergy
Academic Article Sublingual immunotherapy for peanut allergy: A randomized, double-blind, placebo-controlled multicenter trial (CoFAR
Academic Article Basophil suppression in peanut allergy patients undergoing peanut oral immunotherapy (OIT)
Academic Article Oral peanut immunotherapy for children with peanut allergy
Academic Article Improvement of quality of life in children with peanut allergy upon development of tolerance to peanut
Academic Article Natural course of egg, milk and peanut allergy using a novel diagnostic scheme: 1 year follow-up in an observational study (CoFAR2) of food allergy
Academic Article Threshold dose for peanut allergy during peanut oral immunotherapy procedure in children
Academic Article Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy.
Academic Article Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial.
Academic Article Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the Viaskin patch.
Academic Article Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel.
Academic Article Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel.
Academic Article Addendum guidelines for the prevention of peanut allergy in the United States: Summary of the National Institute of Allergy and Infectious Diseases-sponsored expert panel.
Academic Article Addendum Guidelines for the Prevention of Peanut Allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases-Sponsored Expert Panel.
Academic Article Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy.
Academic Article Addendum Guidelines for the Prevention of Peanut Allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases-Sponsored Expert Panel.
Academic Article Addendum guidelines for the prevention of peanut allergy in the United States.
Academic Article Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults.
Academic Article Food Allergy.
Academic Article Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial.
Academic Article Single-cell profiling of peanut-responsive T cells in patients with peanut allergy reveals heterogeneous effector TH2 subsets.
Academic Article Addendum Guidelines for the Prevention of Peanut Allergy in the United States: Summary of the National Institute of Allergy and Infectious Diseases-Sponsored Expert Panel.
Academic Article AR101 Oral Immunotherapy for Peanut Allergy.
Grant Oral Therapy for Peanut Allergy-Supplement
Academic Article Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial.
Academic Article Clinical factors associated with peanut allergy in a high-risk infant cohort.
Academic Article Dual transcriptomic and epigenomic study of reaction severity in peanut-allergic children.
Academic Article Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results.
Academic Article Early epitope-specific IgE antibodies are predictive of childhood peanut allergy.
Academic Article Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy Research.
Academic Article Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study.
Academic Article Open-label follow-on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy.
Academic Article Allergen-specific T cells and clinical features of food allergy: Lessons from CoFAR immunotherapy cohorts.
Academic Article Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study.
Academic Article Safety of peanut (Arachis hypogaea) allergen powder-dnfp in children and teenagers with peanut allergy: Pooled summary of phase 3 and extension trials.
Grant Oral Therapy for Peanut Allergy-Supplement
Grant Immunology of Peanut Allergy and its Treatment: A Prototype
Academic Article Peanut-Specific IgG4 and IgA in Saliva Are Modulated by Peanut Oral Immunotherapy.
Academic Article HLA-associated outcomes in peanut oral immunotherapy trials identify mechanistic and clinical determinants of therapeutic success.
Academic Article Food-specific immunoglobulin A does not correlate with natural tolerance to peanut or egg allergens.
Academic Article Distinct trajectories distinguish antigen-specific T cells in peanut-allergic individuals undergoing oral immunotherapy.
Academic Article Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy.
Academic Article Longitudinal dynamics of the gut microbiome and metabolome in peanut allergy development.
Academic Article Oral Immunotherapy for Peanut Allergy in Children 1 to Less Than 4 Years of Age.
Academic Article Omalizumab for the Treatment of Multiple Food Allergies.

Search Criteria
  • Peanut Hypersensitivity